Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-26-030041
Filing Date
2026-03-18
Accepted
2026-03-18 09:13:06
Documents
2
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2492
2 POWER OF ATTORNEY ea028234102ex24.htm EX-24 7659
  Complete submission text file 0001213900-26-030041.txt   11771
Mailing Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG China
Business Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG China 852 2155 0823
Regencell Bioscience Holdings Ltd (Issuer) CIK: 0001829667 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address 9/F CHINACHEM LEIGHTON PLAZA 29 LEIGHTON ROAD CAUSEWAY BAY Hong Kong 00000
Business Address
AU YAT-PUI (Reporting) CIK: 0002112717 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40617 | Film No.: 26766052